Close
Close
Actinium Receives Positive from EMA for AML
570 views
2.6 from 8 votes

Executive Chairman of Actinium Pharmaceuticals discusses his company's positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) related to the EU approval pathway for Actinium, an Acute Myeloid Leukemia (AML) drug.

Learn more about:

Access Programs

by Abidemi Uruejoma
3 views 18 minutes ago
by Abidemi Uruejoma
1 views 47 minutes ago
by Abidemi Uruejoma
14 views 1 week ago
by Abidemi Uruejoma
29 views 1 week ago
by Abidemi Uruejoma
27 views 1 week ago
by Abidemi Uruejoma
55 views 1 month ago
by Abidemi Uruejoma
74 views 1 month ago
by Abidemi Uruejoma
71 views 1 month ago
2.6 from 8 votes
Free Newsletter
Find a Clinical Trial
Related Videos
News Articles